Try it
General Medicine · Respiratory medicine: antituberculosis drug hepatotoxicity
Sample itemA 40-year-old woman, 3 weeks into isoniazid, rifampicin, pyrazinamide and ethambutol, develops nausea and jaundice. ALT is 520 U/L (about ten times the upper limit) and bilirubin is 4 mg/dL. What is the best step?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Stop the hepatotoxic drugs and reintroduce them one by one after recovery
Jaundice with ALT above three times normal on symptoms means drug-induced liver injury. All potentially hepatotoxic drugs (isoniazid, rifampicin, pyrazinamide) are stopped, a non-hepatotoxic regimen can bridge if needed, and the drugs are reintroduced sequentially once the liver tests settle.
Option by option
A. Continue all drugs and halve the doses until the enzymes fall
Halving doses while continuing risks fulminant hepatitis and is not recommended.
B. Stop the hepatotoxic drugs and reintroduce them one by one after recovery (correct)
Correct. Stopping the hepatotoxic drugs and rechallenging sequentially identifies the culprit safely.
C. Stop only pyrazinamide and continue the other drugs
Isoniazid and rifampicin are also hepatotoxic, so stopping only pyrazinamide is inadequate.
D. Continue the regimen and add silymarin to protect the liver
Silymarin has no proven protective effect and does not justify continuing the drugs.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…